Performance of the COPD Assessment Test in patients with connective tissue disease-associated interstitial lung disease.


Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
04 2019
Historique:
received: 01 08 2018
revised: 30 11 2018
accepted: 26 01 2019
entrez: 10 4 2019
pubmed: 10 4 2019
medline: 2 5 2020
Statut: ppublish

Résumé

Patients with connective tissue disease-associated interstitial lung disease (CTD-ILD) often experience impaired health status. In daily clinical practice, a short and easy instrument for assessing health status would be useful to help better understand the patient's condition. The COPD Assessment Test (CAT) is a simple questionnaire about respiratory symptoms and their impact. We aimed to examine the CAT's performance characteristics and to generate data to support its reliability and validity in patients with CTD-ILD. We used data from 132 CTD-ILD patients evaluated at Tosei General Hospital from July 2011 to July 2016 to assess the cross-sectional and longitudinal validity of the CAT. The mean age of the patients was 64.5 years and 87 (66%) were women. There were no significant differences in CAT score between any of the CTD subgroups. Internal consistency (Cronbach's α = 0.881) and repeatability (intraclass correlation coefficient [ICC] = 0.803) for the CAT score were acceptable. At baseline, CAT score was significantly associated with clinically meaningful measures of physiologic function, exercise capacity, and dyspnea. Change in CAT score over 6-12 months was also associated with change in other measures. In the distribution- and anchor-based analyses, the estimated minimal clinically important difference of CAT score was 1-4 points. These data support the validity and reliability of CAT as a sensitive measure for assessing health status in patients with CTD-ILD.

Sections du résumé

BACKGROUND
Patients with connective tissue disease-associated interstitial lung disease (CTD-ILD) often experience impaired health status. In daily clinical practice, a short and easy instrument for assessing health status would be useful to help better understand the patient's condition. The COPD Assessment Test (CAT) is a simple questionnaire about respiratory symptoms and their impact. We aimed to examine the CAT's performance characteristics and to generate data to support its reliability and validity in patients with CTD-ILD.
METHODS
We used data from 132 CTD-ILD patients evaluated at Tosei General Hospital from July 2011 to July 2016 to assess the cross-sectional and longitudinal validity of the CAT.
RESULTS
The mean age of the patients was 64.5 years and 87 (66%) were women. There were no significant differences in CAT score between any of the CTD subgroups. Internal consistency (Cronbach's α = 0.881) and repeatability (intraclass correlation coefficient [ICC] = 0.803) for the CAT score were acceptable. At baseline, CAT score was significantly associated with clinically meaningful measures of physiologic function, exercise capacity, and dyspnea. Change in CAT score over 6-12 months was also associated with change in other measures. In the distribution- and anchor-based analyses, the estimated minimal clinically important difference of CAT score was 1-4 points.
CONCLUSION
These data support the validity and reliability of CAT as a sensitive measure for assessing health status in patients with CTD-ILD.

Identifiants

pubmed: 30961943
pii: S0954-6111(19)30033-2
doi: 10.1016/j.rmed.2019.01.017
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-20

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Atsushi Suzuki (A)

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Electronic address: suzukia@med.nagoya-u.ac.jp.

Yasuhiro Kondoh (Y)

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan. Electronic address: konyasu2003@yahoo.co.jp.

Jeffrey James Swigris (JJ)

Department of Medicine, National Jewish Health, Denver, CO, USA. Electronic address: SwigrisJ@NJHealth.org.

Toshiaki Matsuda (T)

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan. Electronic address: tmatsuda@tosei.or.jp.

Tomoki Kimura (T)

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan. Electronic address: tomoki_kimura@tosei.or.jp.

Kensuke Kataoka (K)

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan. Electronic address: kataoka@tosei.or.jp.

Masahiko Ando (M)

Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Aichi, Japan. Electronic address: mando.tsuru@gmail.com.

Naozumi Hashimoto (N)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Electronic address: hashinao@med.nagoya-u.ac.jp.

Koji Sakamoto (K)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Electronic address: sakakoji@med.nagoya-u.ac.jp.

Yoshinori Hasegawa (Y)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Electronic address: yhasega@med.nagoya-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH